Agents useful for treating obesity, diabetes and related disorders
First Claim
1. A method of treating impaired insulin sensitivity, impaired glucose tolerance or obesity, comprising administering to a subject having the impaired insulin sensitivity, glucose tolerance or obesity an effective regime of idebenone as sole active agent, or a pharmaceutically acceptable salt thereof, thereby treating impaired insulin sensitivity, impaired glucose tolerance or obesity.
4 Assignments
0 Petitions
Accused Products
Abstract
This invention provides methods of identifying agents useful to prevent, ameliorate or treat one or more symptoms of impaired insulin sensitivity, glucose tolerance, obesity, diabetes, aging, metabolic syndrome, or other metabolic syndrome component diseases, and methods of employing the identified agents to prevent, reduce, delay or inhibit one or more symptoms of impaired insulin sensitivity, glucose tolerance, obesity, diabetes, aging, metabolic syndrome, or other metabolic syndrome component diseases.
41 Citations
20 Claims
- 1. A method of treating impaired insulin sensitivity, impaired glucose tolerance or obesity, comprising administering to a subject having the impaired insulin sensitivity, glucose tolerance or obesity an effective regime of idebenone as sole active agent, or a pharmaceutically acceptable salt thereof, thereby treating impaired insulin sensitivity, impaired glucose tolerance or obesity.
- 11. A method of treating impaired insulin sensitivity, impaired glucose tolerance or obesity, comprising co-administering to the subject having the impaired insulin sensitivity, glucose tolerance or obesity an effective regime of idebenone and Src I-1, or a pharmaceutically acceptable salt thereof, thereby treating impaired insulin sensitivity, impaired glucose tolerance or obesity.
Specification